Sort
51,593 grants matching “hepatitis”
INVARIANCE MAPPING OF THE COMPLETE HBV GENOME AND TESTING OF MRE11 REPAIR NUCLEASE TOWARD THE IMPROVEMENT OF CRISPR/CAS THERAPY FOR HEPATITIS B
$1,878,970Invvax, Inc. · · FY2022 · Department of the Army
Liver Cancer Control Interventions for Asian Americans
$1,878,844Moon S Chen · University Of California At Davis · P01 · FY2006 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,877,686Washington University · U01 · FY2003 · AI
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$1,877,496Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2021 · AI
ENHANCING MODELS OF HIV, VIRAL HEPATITIS, STIs, AND TUBERCULOSIS TO INFORM AND IMPROVE PUBLIC HEALTH IMPACT
$1,876,986Patrick Sullivan · Emory University · U38 · FY2015 · PS
New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency
$1,876,851David H Perlmutter · Washington University · P01 · FY2022 · DK
Hepatitis C Clinical Trial-Data Coordinating Center
$1,875,276Anna Slavin · New England Research Institutes, Inc. · N01 · FY2009 · DK
CENTER FOR PROTEIN STRUCTURE AND FUNCTION
$1,874,433University Of Arkansas At Fayetteville · P20 · FY2000 · RR
TIM family of genes: Role in T cell immunity and tolerance
$1,873,527Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2015 · AI
COBRE Center for Cancer Research Development
$1,873,516Douglas C Hixson · Rhode Island Hospital · P20 · FY2009 · RR
Studies of Rare Cancers
$1,871,915Katherine McGlynn · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
The Ohio State University AIDS Clinical Trials Unit
$1,871,585Susan L Koletar · Ohio State University · UM1 · FY2012 · AI
The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)
$1,871,345Charles W. Flexner · Johns Hopkins University · UM1 · FY2015 · AI
Integrative Metabolic Adaptations to Enviromental and Nutritional Challenge
$1,870,896Klaus H. Kaestner · University Of Pennsylvania · P01 · FY2014 · DK
Molecular signatures for liver cancer diagnosis and treatment stratification
$1,870,751Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence
$1,869,612Fiona Marshall · Heptares Therapeutics, Ltd · R01 · FY2016 · DA
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$1,869,292Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$1,869,242Dana-Farber Cancer Institute · P01 · FY2004 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$1,869,140Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2024 · AI
Mechanisms of GVHD
$1,867,308Joseph H Antin · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Mechanisms of GVHD
$1,867,308Joseph H Antin · Dana-Farber Cancer Inst · P01 · FY2012 · CA
Molecular Regulation Of RNA Metabolism
$1,864,923Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
Lipoprotein Metabolism in Atherosclerosis
$1,864,600Lawrence L Rudel · Wake Forest University Health Sciences · P01 · FY2012 · HL
ADULT AIDS CLINICAL TRIALS UNIT (AACTU)
$1,864,184University Of Rochester · U01 · FY2002 · AI
Bridging the gap between type 2 diabetes GWAS and therapeutic targets
$1,863,743Karen L Mohlke · Univ Of North Carolina Chapel Hill · UM1 · FY2023 · DK